Androgenic Alopecia Treatment
There is more news in the androgenic alopecia space, as Eirion Therapeutics begins a Phase 1 trial for ET-02, a topical treatment. What is ET-02? According to Eirion Therapeutics, ET-02 works by targeting hair follicle stem cells that have become defective or inactive in individuals suffering from androgenic alopecia, enabling hair follicles to resume normal…
Read MoreCorrection (07/05/2024): Topadur Pharma has been in contact (read the comments below) and let us know that TOP-M119 does not contain sildenafil and nitroglycerin. We have corrected the reference to this in the article below. The information originated from a website called Il Messaggero, quote “The most curious thing is that the currently candidate drug,…
Read MoreKintor Pharmaceuticals has announced that its proteolysis targeting chimera (PROTAC) drug GT20029 has reached its primary endpoint in its Phase 2 trial in China. GT20029 is a topical PROTAC targeted toward AGA. What are PROTACs? PROTACs are a novel class of heterobifunctional molecules that can induce the degradation of target proteins by hijacking the cell’s…
Read MorePublished on: Oct 7, 2020 at 20:04
Read MoreAn overview of treatments for pattern baldness and alopecia which will be in the clinical trial stage during 2023. Androgenetic Alopecia Trials Chong Kun Dang Pharmaceutical – We begin the list with a newcomer, previously unannounced. CKD-843 is a new injectable drug being trialed in “alopecia” by the Chong Kun Dang (CKD) Pharmaceutical company of Seoul,…
Read MoreUS Male Phase 2 Pyrilutamide Trial Underway: Update (3/1/22) Consistent progress is the M.O. of Kintor Pharma. On March 1, 2022 it was announced that the first patients in a US phase 2 trial for males have received dosing. The four cohorts in the trial will receive topical dosing of either 2.5 mg pyrilutamide twice…
Read MoreHello everyone, and welcome to another edition of Weekly Thoughts. It has been a little while since my last check in with you all. You can chalk it up to a busy schedule and the fact that there hasn’t been too much significant news in the hair growth treatment world recently. As always, there are…
Read MoreThe times they are a-changing. Nowadays you can’t even take a trip to the fridge to grab more hummus dip without some hair growth startup rolling out their new website and business plan. Jokes aside, Follica has been the ultimate tight-lipped company in the hair regeneration biz for about 8 years now. To be honest,…
Read MoreHello everyone, and welcome to another edition of Weekly Thoughts. Things have been really busy in the hair world as of late, new companies are popping up all the time and companies that we have known about are finally making the announcements we want to hear. Lo and behold it’s almost been two months since…
Read MoreI’m very happy to be bringing you all an incredible exclusive on Follicle Thought. This week, David Weinstein, MD, PhD of RiverTown Therapeutics Inc. reached out to me to share some amazing photo results of his new compound RT1640. Below you will find photographs of a 60+ year old woman and a 42 year old…
Read More